Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta‐analysis of case series studies

  title={Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta‐analysis of case series studies},
  author={Regina El Dib and Naji J Touma and Anil Kapoor},
  journal={BJU International},
Study Type – Therapy (systematic review) 
Percutaneous microwave ablation of renal masses in a UK cohort
To report a tertiary referral centre’s experience of microwave ablation (MWA) for suspected renal cell carcinoma (RCC), describing complications and oncological outcomes.
Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trial
To assess the feasibility and safety of stereotactic ablative body radiotherapy for renal cell carcinoma (RCC) in patients unsuitable for surgery, and to assess oncological and functional outcomes.
Cryoablation Predisposes to Higher Cancer Specific Mortality Relative to Partial Nephrectomy in Patients with Nonmetastatic pT1b Kidney Cancer
Cryoablation is done in select patients with pT1b nonmetastatic renal cell carcinoma without convincing proof of efficacy, and differences in the cancer specific mortali...
Postoperative Surveillance Protocols for Renal Cell Carcinoma
Patients with renal cell carcinoma (RCC) are at risk of recurrence even after definitive surgical extirpation, and surveillance in the postoperative setting is of paramount importance.
Renal ablation: current management strategies and controversies.
An overview of the current types of ablative technology is outlined, the current evidence and controversies are presented and controversies on image-guided renal ablation are discussed.
Trends in Percutaneous Thermal Ablation Therapies in the Treatment of T1a Renal Cell Carcinomas Rather than Partial Nephrectomy/Radical Nephrectomy.
The purpose of this article is to review the principal thermal ablation modalities and oncological outcomes for the treatment of stage T1 RCCs with long-term follow-up.
Surgical and Medical Options in the Management of Renal Cell Carcinoma
A review of various histologic subtypes of RCC, up-to-date surgical and medical treatment options, and their respective outcomes is presented.
Decision Making: Thermal Ablation Options for Small Renal Masses.
Those patients with small renal masses, typically less than 3 to 4 cm in size who are deemed unsuitable for surgery, may be suitable for percutaneous thermal ablation, and the various treatment modalities are reviewed.
Population‐based assessment of cancer‐specific mortality after local tumour ablation or observation for kidney cancer: a competing risks analysis
Differences in cancer‐specific mortality (CSM) that might distinguish between local tumour ablation (LTA) and observation (OBS) for patients with kidney cancer are examined.


Percutaneous cryoablation of renal cell carcinoma guided by horizontal open magnetic resonance imaging
This study aims to determine the feasibility, safety, and intermediate‐term treatment outcome of percutaneous cryoablation of renal cell carcinoma guided by horizontal open magnetic resonance imaging (MRI).
‘Skipping’ is still a problem with radiofrequency ablation of small renal tumours
To evaluate the homogeneity and extent of necrosis obtained with next‐generation radiofrequency ablation (RFA) equipment and techniques, as incomplete tumour necrosis, or ‘skipping’, has been
Follow‐up of renal masses after cryosurgery using computed tomography; enhancement patterns and cryolesion size
The characteristics of cryolesions as seen on computed tomography (CT) are described, for size and enhancement patterns, and correlations between these imaging findings and histopathological diagnosis are assessed.
Laparoscopic cryoablation of solid renal masses: intermediate term followup.
LRC for small renal masses appears to be a safe, reproducible, minimally invasive technique, although further studies and prolonged followup are needed to access the role of this surgical technique.
Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes.
Renal function appears to be adequately maintained with promising oncologic outcomes at 2.5 years following RFA and radiofrequency ablation is an attractive alternative for the management of patients with T1a renal cortical tumors in a solitary kidney.
Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors.
RF ablation of RCC can be successful in exophytic RCC tumors up to 5.0 cm in size and presence of a tumor component in the renal sinus was a significant negative predictor of technical success.
Management of Renal Tumors by Image-Guided Radiofrequency Ablation: Experience in 105 Tumors
The experience to date suggests that RFA is a safe and effective, minimally invasive treatment for small renal tumors, and tumor size is the only significant variable affecting procedural outcome.